iShares Genomics Immunology and Healthcare ETF (IDNA) price, chart and fund profile
Price chart
Fund profile
IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.
- Issuer
- BlackRock Fund Advisors
- Industry
- Theme
- Inception
- Jun 11, 2019
- Assets under management
- $313.7M
- Expense ratio
- 0.47%
- Net asset value
- $41.28
- NAV as of
- Oct 14, 2026
- Leverage
- 1×
- Fund page
- www.ishares.com↗
Frequently asked questions
What is iShares Genomics Immunology and Healthcare ETF (IDNA)?
IDNA tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering.
What is IDNA's expense ratio?
iShares Genomics Immunology and Healthcare ETF charges an annual expense ratio of 0.47%. The fund is issued by BlackRock Fund Advisors.
How large is IDNA?
iShares Genomics Immunology and Healthcare ETF manages $313.7M in assets and has traded since Jun 11, 2019.
How do I buy shares of iShares Genomics Immunology and Healthcare ETF (IDNA)?
IDNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.